Literature DB >> 8316435

Reinfection with hookworm after chemotherapy in Papua New Guinea.

R J Quinnell1, A F Slater, P Tighe, E A Walsh, A E Keymer, D I Pritchard.   

Abstract

Reinfection with hookworm (Necator americanus) following chemotherapy was studied over 2 years in a rural village in Madang Province, Papua New Guinea. The prevalence of hookworm infection had returned to pre-treatment levels after 2 years, and the geometric mean hookworm burden had returned to 58% of the pre-treatment value. The rate of acquisition of adult worms was independent of host age, and was estimated as a geometric mean of 2.9-3.3 worms/host/year (arithmetic mean 7.9-8.9 worms/host/year). There was significant predisposition to hookworm infection; the strength of this predisposition did not vary significantly between age or sex classes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8316435     DOI: 10.1017/s0031182000067123

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  23 in total

1.  Modelling heterogeneity and the impact of chemotherapy and vaccination against human hookworm.

Authors:  L Sabatelli; A C Ghani; L C Rodrigues; P J Hotez; S Brooker
Journal:  J R Soc Interface       Date:  2008-11-06       Impact factor: 4.118

2.  Role for nitric oxide in hookworm-associated immune suppression.

Authors:  Blaise Dondji; Richard D Bungiro; Lisa M Harrison; Jon J Vermeire; Carlo Bifulco; Diane McMahon-Pratt; Michael Cappello
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

3.  Genetic Markers of Benzimidazole Resistance among Human Hookworms (Necator americanus) in Kintampo North Municipality, Ghana.

Authors:  Ambrose R Orr; Josephine E Quagraine; Peter Suwondo; Santosh George; Lisa M Harrison; Fabio Pio Dornas; Benjamin Evans; Adalgisa Caccone; Debbie Humphries; Michael D Wilson; Michael Cappello
Journal:  Am J Trop Med Hyg       Date:  2019-02       Impact factor: 2.345

4.  Host cytokine production, lymphoproliferation, and antibody responses during the course of Ancylostoma ceylanicum infection in the Golden Syrian hamster.

Authors:  Susana Mendez; Jesus G Valenzuela; Wenhui Wu; Peter J Hotez
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

Review 5.  Human hookworm infection in the 21st century.

Authors:  Simon Brooker; Jeffrey Bethony; Peter J Hotez
Journal:  Adv Parasitol       Date:  2004       Impact factor: 3.870

6.  Effect of heterogeneous mixing and vaccination on the dynamics of anthelmintic resistance: a nested model.

Authors:  Lorenzo Sabatelli
Journal:  PLoS One       Date:  2010-05-18       Impact factor: 3.240

Review 7.  Impact of hookworm infection and deworming on anaemia in non-pregnant populations: a systematic review.

Authors:  Jennifer L Smith; Simon Brooker
Journal:  Trop Med Int Health       Date:  2010-05-25       Impact factor: 2.622

8.  Oral transfer of adult Ancylostoma ceylanicum hookworms into permissive and nonpermissive host species.

Authors:  Richard D Bungiro; Brett R Anderson; Michael Cappello
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

9.  Purification and molecular cloning of and immunization with Ancylostoma ceylanicum excretory-secretory protein 2, an immunoreactive protein produced by adult hookworms.

Authors:  Richard D Bungiro; Carolina V Solis; Lisa M Harrison; Michael Cappello
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

10.  The control of hookworm infection in China.

Authors:  Qi Zheng; Ying Chen; Hao-Bing Zhang; Jia-Xu Chen; Xiao-Nong Zhou
Journal:  Parasit Vectors       Date:  2009-09-24       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.